Tilray Brands Inc (TLRY)
1.973
+0.02
(+1.20%)
USD |
NASDAQ |
May 09, 16:00
2.01
+0.04
(+1.85%)
After-Hours: 20:00
Tilray Brands Total Return Level: 1.973 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 1.973 |
May 08, 2024 | 1.95 |
May 07, 2024 | 1.98 |
May 06, 2024 | 2.05 |
May 03, 2024 | 2.10 |
May 02, 2024 | 2.02 |
May 01, 2024 | 2.02 |
April 30, 2024 | 2.47 |
April 29, 2024 | 1.77 |
April 26, 2024 | 1.78 |
April 25, 2024 | 1.75 |
April 24, 2024 | 1.84 |
April 23, 2024 | 1.84 |
April 22, 2024 | 1.72 |
April 19, 2024 | 1.73 |
April 18, 2024 | 1.72 |
April 17, 2024 | 1.72 |
April 16, 2024 | 1.83 |
April 15, 2024 | 1.78 |
April 12, 2024 | 1.82 |
April 11, 2024 | 1.90 |
April 10, 2024 | 2.02 |
April 09, 2024 | 2.055 |
April 08, 2024 | 2.59 |
April 05, 2024 | 2.595 |
Date | Value |
---|---|
April 04, 2024 | 2.68 |
April 03, 2024 | 2.85 |
April 02, 2024 | 2.41 |
April 01, 2024 | 2.43 |
March 28, 2024 | 2.47 |
March 27, 2024 | 2.48 |
March 26, 2024 | 2.31 |
March 25, 2024 | 2.15 |
March 22, 2024 | 2.31 |
March 21, 2024 | 1.95 |
March 20, 2024 | 1.98 |
March 19, 2024 | 1.92 |
March 18, 2024 | 1.92 |
March 15, 2024 | 1.73 |
March 14, 2024 | 1.60 |
March 13, 2024 | 1.67 |
March 12, 2024 | 1.68 |
March 11, 2024 | 1.67 |
March 08, 2024 | 1.70 |
March 07, 2024 | 1.64 |
March 06, 2024 | 1.63 |
March 05, 2024 | 1.65 |
March 04, 2024 | 1.70 |
March 01, 2024 | 1.73 |
February 29, 2024 | 1.73 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.52
Minimum
Jun 23 2023
31.38
Maximum
Feb 10 2021
6.551
Average
5.298
Median
Jun 01 2020
Total Return Level Benchmarks
Clever Leaves Holdings Inc | 2.47 |
Flora Growth Corp | 1.42 |
Acasti Pharma Inc | 2.76 |
Aurinia Pharmaceuticals Inc | 5.172 |
Edesa Biotech Inc | 4.514 |